Section 4: β-cell mass and function in type 2 diabetes IRS proteins and β-cell function

Diabetes

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Burks, Deborah J ^a   White, Morris F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE 2 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-2 PROTEIN; IRS3L PROTEIN, HUMAN; IRS4 PROTEIN, HUMAN; IRS4 PROTEIN, MOUSE; PHOSPHOPROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

APOPTOSIS; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; CELL COUNT; CELL DIVISION; CYTOLOGY; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELL COUNT; CELL DIVISION; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION;

EID: 0035125526     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2007.s140     Document Type: Conference Paper

References (54)

1. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
2. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
3. Insulin resistance or insulin deficiency: Which is the primary cause of NIDDM?
4. β-cell reserve: Compensatory mechanisms of the β-cell
5. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat
6. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
7. Disruption of IRS-2 causes type 2 diabetes in mice
8. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling
9. Interactive roles of Ras, IRS-1 and proteins with SH2 domains in insulin signaling in Xenopus oocytes
10. Insulin signal transduction and the IRS proteins
11. The IRS-signaling system during insulin and cytokine action
12. Role of insulin-like growth factors in embryonic and postnatal growth
13. Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells
14. Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase
15. A lipid-anchored Grb-2 binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway
16. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok
17. Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin
18. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
19. Role of IRS-2 in insulin and cytokine signalling
20. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family
21. A novel 160 kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family
22. Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 gene
23. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling
24. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes
25. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
26. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
27. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice
28. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
29. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer
30. The beta cell transcription factors and development of the pancreas
31. Developmental biology of the pancreas
32. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent: Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells
33. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
34. Insulin and IGF-1 receptors signaling in protection from apoptosis
35. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
36. The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin
37. Dynamics of β-cell mass in the growing rat pancreas: Estimation with a simple mathematical model
38. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines
39. 2+ stores in insulin-stimulated insulin secretion in β-cells
40. 2+ uptake in β-cells
41. 2+ regulates calmodulin binding to IQ motifs in IRS-1
42. 2+/calmodulin-dependant protein kinase II in insulinoma MIN6 cells
43. 2+-ATPases in muscle and heart
44. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling: Evidence from transfection studies
45. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
46. The Gly972 to Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β cells
47. Insulin secretion: Feed-forward control of insulin biosynthesis?
48. Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that in type 2 diabetes
49. Loss of cdk4 expression causes insulin-deficient diabetes and cdk4 activation results in β-islet cell hyperplasia
50. Structural and functional properties of ras proteins
51. Diabetes induced in male transgenic mice by expression of human H-ras oncoprotein in pancreatic β cells
52. Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration
53. Multiple ras effector pathways contribute to G(1) cell cycle progression
54. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis